Global Patent Index - EP 3400442 A4

EP 3400442 A4 20190626 - BETA-GLUCAN IMMUNOTHERAPIES AFFECTING THE IMMUNE MICROENVIRONMENT

Title (en)

BETA-GLUCAN IMMUNOTHERAPIES AFFECTING THE IMMUNE MICROENVIRONMENT

Title (de)

BETA-GLUCAN-IMMUNTHERAPIEN MIT BEEINFLUSSUNG DER MIKROUMGEBUNG DES IMMUNSYSTEMS

Title (fr)

IMMUNOTHÉRAPIES PAR BÊTA-GLUCANE AFFECTANT LE MICROENVIRONNEMENT IMMUNITAIRE

Publication

EP 3400442 A4 20190626 (EN)

Application

EP 17736531 A 20170109

Priority

  • US 201662276667 P 20160108
  • US 2017012766 W 20170109

Abstract (en)

[origin: WO2017120604A1] This disclosure relates to soluble β-glucan immunotherapies that affect the tumor microenvironment. The soluble β-glucan immunotherapies promote an immunostimulatory environment, which enhances the effectiveness of the combination of anti-angiogenics and checkpoint inhibitors.

IPC 8 full level

G01N 33/569 (2006.01); A61K 31/716 (2006.01)

CPC (source: EP US)

A61K 31/716 (2013.01 - EP US); A61K 39/39 (2013.01 - EP US); A61K 39/39533 (2013.01 - US); A61K 45/06 (2013.01 - EP US); A61P 35/00 (2017.12 - EP US); C07K 16/2827 (2013.01 - US); C07K 16/2863 (2013.01 - US); G01N 33/54366 (2013.01 - EP US); G01N 33/569 (2013.01 - EP US); A61K 2039/507 (2013.01 - EP US); A61K 2039/55583 (2013.01 - EP US)

Citation (search report)

  • [Y] WO 2015095811 A2 20150625 - BOARD INST INC [US], et al
  • [Y] CLIVE S. ZENT ET AL: "Early treatment of high risk chronic lymphocytic leukemia with alemtuzumab, rituximab and poly-(1-6)-beta-glucotriosyl-(1-3)- beta-glucopyranose beta-glucan is well tolerated and achieves high complete remission rates", LEUKEMIA AND LYMPHOMA., vol. 56, no. 8, 3 August 2015 (2015-08-03), US, pages 2373 - 2378, XP055588158, ISSN: 1042-8194, DOI: 10.3109/10428194.2015.1016932
  • [Y] S. YASUDA ET AL: "Simultaneous blockade of programmed death 1 and vascular endothelial growth factor receptor 2 (VEGFR2) induces synergistic anti-tumour effect in vivo", CLINICAL & EXPERIMENTAL IMMUNOLOGY, vol. 172, no. 3, 18 April 2013 (2013-04-18), pages 500 - 506, XP055180642, ISSN: 0009-9104, DOI: 10.1111/cei.12069
  • See references of WO 2017120604A1

Designated contracting state (EPC)

AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DOCDB simple family (publication)

WO 2017120604 A1 20170713; EP 3400442 A1 20181114; EP 3400442 A4 20190626; US 2019022129 A1 20190124; US 2022117998 A1 20220421; US 2023172967 A1 20230608

DOCDB simple family (application)

US 2017012766 W 20170109; EP 17736531 A 20170109; US 201716068868 A 20170109; US 202117566133 A 20211230; US 202217887144 A 20220812